From classroom to clinic: sodium–glucose co-transporter 2 inhibitor evidence in practice.
Congress Presentation
About the speakers
Professor Subodh Verma
Professor Martin Cowie
Doctor Stephen Wiviott
Professor Alexandre Mebazaa
5 more presentations in this session
Welcome and introductions - Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes.
Speaker: Professor A. Mebazaa (Paris, FR)
What have cardiovascular outcomes trials taught us about cardiovascular risk management?
Speaker: Professor M. Pfeffer (Boston, US)
What we still need to learn from sodium–glucose co-transporter 2 inhibitors to predict the future.
Speaker: Professor M. Cowie (Cambridge, GB)
Q&A - Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes.
Speaker: Professor S. Verma (Toronto, CA) Professor M. Cowie (Cambridge, GB) Professor A. Mebazaa (Paris, FR) Professor M. Pfeffer (Boston, US)
Access the full session
Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes (EBAC Accredited)
About the event
ESC 365 is supported by
